Genetic and Metabolic Determinants of Plasma PCSK9 Levels
AUTOR(ES)
Lakoski, Susan G.
FONTE
The Endocrine Society
RESUMO
Context: PCSK9 is a secreted protein that influences plasma levels of low-density lipoprotein cholesterol (LDL-C) and susceptibility to coronary heart disease. PCSK9 is present in human plasma, but the factors that contribute to differences in plasma concentrations of PCSK9 and how they impact on the levels of lipoproteins have not been well-characterized.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2708952Documentos Relacionados
- Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9
- Function and distribution of circulating human PCSK9 expressed extrahepatically in transgenic mice
- PCSK9 Inhibitors: Clinical Relevance, Molecular Mechanisms, and Safety in Clinical Practice
- De Volta ao Basico: PCSK9 como um Novo Alvo para o Receptor LDL
- Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment
